- ￥10600 - 17500
- TargetMol
- 美国
- T62651
- 2025年07月11日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
零下80~20°C
- 保质期：
Powder: -20°C for 3 years In solvent: -80°C for 2 years
- 英文名：
ATR-IN-11
- 库存：
10
- 供应商：
TargetMol
- 规格：
100 mg/25 mg/50 mg
| 规格： | 100 mg | 产品价格： | ￥17500.0 |
|---|---|---|---|
| 规格： | 25 mg | 产品价格： | ￥10600.0 |
| 规格： | 50 mg | 产品价格： | ￥13800.0 |
Product Introduction
Bioactivity
英文名:ATR-IN-11
描述:ATR-IN-11 (Compound Hit01) is a potent inhibitor of ataxia capillaris and Rad3-related (ATR) kinases. ATR-IN-11 is a promising lead compound for the discovery of subsequent drugs targeting the ATR kinase, a key regulatory protein in the DNA damage response (DDR) responsible for sensing replication stress (RS). ATR-IN-11 has potential for cancer disease research.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验11-脱氧皮质〔甾〕酮 11-deoxycorticosterone
C21 H30 O3 ， 21-羟基孕烯 -4-二酮 -3， 20。也单称脱氧皮质〔甾〕酮，或缩写 DOC。是副肾皮质激素的一种，具有糖代谢作用。由副肾皮质细胞的微粒体的 21-羟化酶的作用，从黄体酮进行生物合成的。其乙酸酯缩写为 DOCA，应用于临床。由于在副肾皮质细胞的线粒体中的 11β -羟化酶的作用可生成皮质酮，所以通常也认为是一种中间体。
Identifying Inhibitors of ATM and ATR Kinase Activities
The Ataxia Telangiectasia mutated (ATM) and the ATM and Rad3-related (ATR) proteins function in partially overlapping DNA damage checkpoint pathways that orchestrate the cellular response to DNA damage. Both proteins belong to a growing
A Human Cell Extract-Based Assay for the Activation of ATM and ATR Checkpoint Kinases
The Ataxia telangiectasia -mutated (ATM) and the ATM-Rad3-related (ATR) kinases are master regulators of the DNA damage-signaling pathways that respond to a wide variety of DNA damage. In this chapter, we describe an in vitro biochemical
技术资料暂无技术资料 索取技术资料
